Scarica l'app Stockscreener
26.18
1.16%
-0.50
Spyglass Pharma Inc Borsa (SGP) Ultime notizie
Spyglass Pharma (SGP) Insider Trading Activity 2026 $SGP - MarketBeat
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit - Bitget
1-on-1 meetings with SpyGlass Pharma at Miami biotech summit - Stock Titan
Spyglass Pharma (NASDAQ:SGP) Coverage Initiated by Analysts at Citigroup - Defense World
Stifel Initiates Coverage of SpyGlass Pharma (SGP) with Buy Recommendation - Nasdaq
Spyglass Pharma (NASDAQ:SGP) Now Covered by Stifel Nicolaus - MarketBeat
Leerink Initiates SpyGlass Pharma at Outperform With $42 Price Target - marketscreener.com
Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target - marketscreener.com
Stifel initiates SpyGlass Pharma stock with buy rating on glaucoma device potential - Investing.com Canada
Spyglass Pharma (SGP) Stock Price, News & Analysis $SGP - MarketBeat
Top Spyglass Pharma (SGP) Competitors 2026 - MarketBeat
Spyglass Pharma (SGP) Stock Trends and Sentiment 2026 $SGP - MarketBeat
New Enterprise Associates 17, L.P. Increases Stake in SpyGlass P - GuruFocus
NEA 17 (SGP) converts preferred and buys 937,500 SpyGlass Pharma shares - Stock Titan
Latham & Watkins Advises on SpyGlass Pharma’s US$150 Million Initial Public Offering - Legal Desire Media and Insights
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares - The Manila Times
SpyGlass Pharma Closes $172.5 Million IPO - marketscreener.com
SpyGlass Pharma (Nasdaq: SGP) closes $172.5M IPO at $16 per share - Stock Titan
SpyGlass Pharma closes $172.5 million IPO on NASDAQ By Investing.com - Investing.com Nigeria
SpyGlass Pharma closes $172.5 million IPO on NASDAQ - Investing.com South Africa
SpyGlass Pharma Announces Closing of Initial Public - GlobeNewswire
Opening Day: SpyGlass Pharma soars in debut after strongly priced IPO - TipRanks
SpyGlass Pharma Raises $150 Million in Initial Public Offering - VisionMonday
SpyGlass Pharma, Inc. (SGP) Eps Diluted (TTM) - Zacks Investment Research
SpyGlass Pharma Inc (SGP): Med-Tech Vision Pays Off: SpyGlass Pharma IPO Pops on Day One - Smartkarma
Eye care firm SpyGlass Pharma soars 65% in trading debut - MSN
SpyGlass Pharma, Developer of Long-Acting Ocular Drug-Delivery Implants for Glaucoma and Other Chronic Eye Conditions, Files for Nasdaq Global Select Market IPO - TradingView
Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO - Bloomberg.com
SpyGlass Pharma and Agomab's Contrasting Nasdaq Debuts - Intellectia AI
Spyglass Pharma shares surge 50% in Nasdaq debut By Investing.com - Investing.com Canada
SpyGlass PharmaSGPStock Price & News - The Motley Fool
SpyGlass Pharma raises $150 million in IPO priced at $16 per share - Investing.com Australia
SpyGlass Pharma Rings the Opening Bell - Nasdaq
SpyGlass Pharma Raises $150 Million in IPO for Eye Condition Treatments - Intellectia AI
SpyGlass Pharma raises $150 million in IPO priced at $16 per share By Investing.com - Investing.com South Africa
SpyGlass Pharma Prices $150 Million IPO - marketscreener.com
Free float of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView
SpyGlass Pharma prices IPO at $16 per share, raising $150 million - Investing.com South Africa
SGP IPO NewsChronic eye condition biotech SpyGlass Pharma prices IPO at $16 midpoint - renaissancecapital.com
Wilson Sonsini Advises SpyGlass Pharma on $150 Million IPO - Wilson Sonsini
SpyGlass Pharma Announces Pricing of Initial Public Offering - Yahoo Finance
SpyGlass Pharma announces pricing of IPO at $16.00 per share - marketscreener.com
Spyglass Pharma Announces Pricing Of IPO At $16.00 Per Share - TradingView
Late-stage biopharma SpyGlass Pharma to debut on Nasdaq after $150M IPO - Stock Titan
SpyGlass Pharma, Inc. Financial Statements – NASDAQ:SGP - TradingView
IPO Rating: Spyglass Pharma Inc. - Smartkarma
SpyGlass Pharma Inc (SGP): IPO Draws Demand as Med-Tech Story Gains Traction - Smartkarma
SpyGlass Pharma Sets Terms for IPO as Ophthalmology-Focused Biotech Advances Sustained-Release Platform - Smartkarma
symbol__ Stock Quote Price and Forecast - CNN
SpyGlass targets $150 million in IPO - The Pharma Letter
SpyGlass Pharma, Inc. (SGP): Glaucoma Care Biotech Sets Terms for IPO, Joins Heavy Issuance Week - Smartkarma
Agomab, SpyGlass firm up IPO plans - FirstWord Pharma
SpyGlass Pharma Sees IPO Ahead For Its Ocular Pressure Treatment Candidates (Pending: SGP) - Seeking Alpha
SpyGlass Pharma, Inc. (SGP): Peeking at the IPO Prospectus Of Company Transforming Glaucoma Care - Smartkarma
SpyGlass Pharma Announces First Patients Randomized in - GlobeNewswire
SpyGlass Pharma Files $100M IPO - Orange County Business Journal
3.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):